A pulmonary embolism happens when a blood clot blocks one of the arteries that carry blood from the heart into the lungs. It is one of the few conditions where minutes genuinely matter, and also one of the most misunderstood, because the test most often associated with it, the D-dimer, is routinely read backwards by patients who see a high number and assume the worst. In this article you will learn which symptoms mean you should call 911 right now, how doctors combine a probability score with a D-dimer result to decide who needs a scan, what troponin, natriuretic peptides, blood gases, blood counts and kidney values add, when clotting-disorder testing helps and when it misleads, and how long treatment usually lasts.
Pulmonary embolism is an emergency: call 911 for these signs
Do not wait for a blood test, a clinic appointment or a symptom to pass. Call 911 immediately if you or someone near you develops any of the following:
- Sudden shortness of breath, at rest or with very little effort
- Chest pain that gets sharper when you breathe in, cough or lie flat
- Coughing up blood or blood-streaked mucus
- Fainting, near-fainting, or a sudden feeling that you are about to collapse
- A racing heartbeat, especially together with breathlessness
- Lips or fingertips turning gray or blue
Three rules matter as much as the symptom list. Do not drive yourself, because a pulmonary embolism can cause a sudden loss of consciousness at the wheel. Do not wait for test results, since diagnosis happens in the emergency department. And do not talk yourself out of it because the pain seems mild; large clots sometimes cause modest symptoms, while small ones can hurt a great deal. If you already take a blood thinner and these symptoms appear, that is still an emergency.
What a pulmonary embolism is and where the clot comes from
The right side of your heart pushes oxygen-poor blood into the pulmonary arteries, which branch through both lungs so the blood can collect oxygen. When a clot lodges in one of those branches, part of the lung still receives air but no longer receives blood. Oxygen transfer drops, breathing speeds up, and the right side of the heart must push against a narrower circuit.
Deep vein thrombosis is the usual source
Most lung clots do not form in the lungs. They form in the deep veins of the calf, thigh or pelvis, a condition called deep vein thrombosis, then break loose and travel through the heart into the lungs. That is why a swollen, warm, aching or discolored calf deserves attention, particularly on one side only. Many people with a pulmonary embolism have no leg symptoms at all, so the absence of swelling never rules anything out. Doctors group both problems under one umbrella term, venous thromboembolism.
Why the heart is part of the story
When enough lung circulation is blocked, the right ventricle becomes strained. That strain separates a clot that can be managed at home from one needing intensive monitoring, and it is why cardiac blood markers appear in a workup that looks, at first glance, entirely about the lungs.
Symptoms, including the ones that are easy to miss
The classic presentation is sudden breathlessness with sharp chest pain that worsens on inhaling, sometimes with a cough. Presentations vary widely, and the quieter versions are the dangerous ones because they get explained away.
- Unexplained breathlessness on climbing stairs you managed easily last week
- A resting pulse above your normal range without a clear cause
- Light-headedness on standing, or unexplained fainting
- Anxiety or sweating arriving with the breathlessness
- A low-grade fever mistaken for a chest infection
- Pain, swelling or a cord-like feeling in one calf
Older adults, people with existing heart or lung disease, and people who are pregnant or recently gave birth are especially likely to be diagnosed late, because breathlessness in those groups has many other plausible explanations.
Risk factors, from long-haul travel to estrogen-containing contraception
Clots form when blood flow slows, when a vein wall is injured, or when blood clots more readily than usual. Most cases combine two or three of these.
- Immobility: hospital stays, bed rest, a leg cast, or long-haul travel of roughly four hours or more in a cramped seat
- Surgery and trauma, especially orthopedic operations on the hip or knee
- Cancer and several cancer treatments, which make blood clot more easily
- Pregnancy, the six weeks after delivery, and estrogen-containing contraception or hormone therapy
- Inherited clotting tendencies and antiphospholipid syndrome
- Obesity, smoking, older age, and a previous clot in yourself or a close relative
The Centers for Disease Control and Prevention publishes a public overview of venous thromboembolism risk factors. On estrogen specifically, the increase in risk is real but small in absolute terms for most healthy non-smokers, and matters most when it stacks with smoking, a personal clot history or a long flight. Many people also want to understand the wording on an oral contraceptive prescription before that conversation with a clinician.
How doctors decide whether you need a scan
Diagnosis is a sequence, not a single test. Skipping a step produces both missed clots and unnecessary radiation.
- Estimate clinical probability first. Structured tools such as the Wells score, the revised Geneva score, the PERC rule and the YEARS algorithm turn findings such as heart rate, leg swelling, cancer history and recent surgery into a low, moderate or high probability.
- Use D-dimer only in the low-to-moderate group. In someone with a high probability, a normal D-dimer is not reassuring enough, and imaging is arranged directly.
- Confirm with imaging. Computed tomography pulmonary angiography, shortened to CTPA, is the standard confirmation test: contrast dye outlines the pulmonary arteries so a clot appears as a gap. A ventilation-perfusion scan is the alternative when contrast is unsafe, and leg vein ultrasound sometimes settles the question without lung imaging.
Two refinements have changed daily practice. The age-adjusted threshold raises the D-dimer cutoff in people over 50 rather than applying one number to every age, and the YEARS approach ties the cutoff to how suspicious the clinical picture looks. Both exist to safely avoid scans that were never going to find anything.
Understanding a D-dimer result
D-dimer is a fragment left behind when the body breaks down a clot it has already formed. Its level rises whenever clotting and clot breakdown are active anywhere in the body, which is why it is powerful in one direction and weak in the other.
It is a rule-out test, not a rule-in test
D-dimer is highly sensitive and poorly specific. In plain terms: if you have a real clot, the test is very likely to be raised, so a normal result in someone at low or moderate clinical probability is genuinely reassuring and imaging can usually be avoided. The reverse is not true. A raised D-dimer only says clot turnover is happening somewhere; it cannot say where, why, or whether it is in your lungs. Read as a standalone number it produces more anxiety than information, which is why it is always interpreted next to a probability score.
What else pushes the number up
The standard cutoff sits around 500 micrograms per liter in fibrinogen-equivalent units, though the exact figure and units depend on which assay your laboratory runs, so results are not comparable between hospitals. Many ordinary situations push a result above that line.
| Situation | Why the D-dimer rises |
|---|---|
| Pregnancy and the weeks after delivery | Clotting activity rises naturally through pregnancy, so levels climb trimester by trimester |
| Infection, including pneumonia and sepsis | Inflammation activates the clotting system body-wide |
| Recent surgery or major injury | Tissue repair involves forming and dissolving small clots |
| Active cancer | Many tumors shift the blood toward a clot-prone state |
| Older age | Baseline levels drift upward with age, hence age-adjusted cutoffs |
| Liver or kidney disease, and being an inpatient | Clearance changes and coexisting illness raise the baseline |
A positive D-dimer therefore does not mean you have a clot; it means the question is still open and imaging is needed to close it. For more detail, read a dedicated guide to D-dimer results.
The other blood tests used around a suspected pulmonary embolism
Once a clot is confirmed, the question changes from whether to how severe, and whether treatment is safe.
| Test | What it contributes |
|---|---|
| Troponin | A protein released when heart muscle is stressed; a raised level suggests strain on the right ventricle and points toward closer monitoring |
| BNP or NT-proBNP | Hormone fragments released when a heart chamber is stretched; used with troponin and ultrasound to separate low-risk from intermediate-risk cases |
| Arterial blood gas | Measures oxygen, carbon dioxide and acid-base balance directly; shows how much gas exchange is lost, though a normal result does not exclude a clot |
| Complete blood count | Checks hemoglobin and platelets before blood thinners begin, and flags anemia or infection that could explain breathlessness |
| Creatinine and estimated filtration rate | Kidney function is checked before contrast dye and again to choose the anticoagulant dose |
| Prothrombin time and partial thromboplastin time | Baseline clotting times recorded before treatment and used to monitor certain therapies |
Each has its own reference range and caveats. It can help to look at an explanation of troponin test results, at a guide to BNP levels or the equivalent guide to NT-proBNP results, and at a walkthrough of a complete blood count. Before contrast imaging, clinicians check a serum creatinine result together with an estimated glomerular filtration rate. Baseline clotting is documented with a prothrombin time measurement and a partial thromboplastin time measurement.
Thrombophilia testing: when it helps and when it misleads
Thrombophilia testing looks for inherited or acquired tendencies to clot: factor V Leiden, the prothrombin gene variant, deficiencies of protein C, protein S or antithrombin, and antiphospholipid antibodies. It is the test patients most often ask for and the one most often ordered at the wrong moment.
Timing is the whole problem. During an acute clot, and while you are taking an anticoagulant, several of these assays give misleading answers: an active clot consumes clotting inhibitors, heparin lowers antithrombin activity, warfarin lowers protein C and protein S, and direct oral anticoagulants interfere with the methods used for lupus anticoagulant. A result taken in those conditions can look abnormal when nothing inherited is present, or normal when something is. Testing is therefore usually deferred until treatment has finished, and reserved for cases where the answer would change a decision: a clot with no provoking factor at a young age, an unusual clot site, recurrent pregnancy loss, or a strong family pattern. If your clinician orders this panel, an explanation of antithrombin III results is a useful starting point.
Treatment, how long it lasts, and the risk of a second clot
Treatment has two aims: stop the clot growing while the body dissolves it, and prevent the next one. Anticoagulants, commonly called blood thinners, do not dissolve an existing clot; they hold the process still so natural clot breakdown can catch up. Direct oral anticoagulants are the usual first choice, with heparin and warfarin still preferred in pregnancy, severe kidney impairment, antiphospholipid syndrome and some cancers.
For a large clot causing dangerously low blood pressure, clot-dissolving drugs, catheter procedures or surgical removal may be used, and a vena cava filter is an option when anticoagulation is impossible. Almost everyone treats for at least three months. What happens next depends on why the clot formed.
- Provoked by a temporary factor such as surgery, a cast or a long flight, now gone: treatment usually stops at three months, because the recurrence risk falls back toward baseline.
- Provoked by an ongoing factor, such as active cancer or an inherited high-risk condition: treatment usually continues while the factor persists.
- Unprovoked, with no identifiable trigger: extended treatment is often recommended, because the risk of another clot stays higher, balanced against bleeding risk.
Recovery is not instant: breathlessness on exertion and reduced stamina commonly last weeks to months, and a minority develop lasting symptoms needing specialist follow-up. Anyone on warfarin becomes familiar with the meaning of an INR value, since the dose is steered by that number.
Latest scientific advances
Research over the past three years has focused less on new drugs and more on sharpening the diagnostic pathway and matching treatment length to each person. Here is what it adds, in plain terms.
A probability estimate tailored to the individual
Researchers pooled the individual records of more than 28,000 people with suspected lung clots from sixteen studies and built a model that estimates each person’s own probability, combining ordinary clinical details with the D-dimer value. Pooling individual records this way is called an individual patient data meta-analysis, one of the more reliable ways to build such a tool. What this means for you: instead of a one-size-fits-all cutoff, your D-dimer result is increasingly read against your own profile, which reduces the number of scans done on people who never needed one.
Adjusted D-dimer thresholds are safe, within limits
A 2024 review comparing age-adjusted cutoffs with probability-adapted cutoffs found both safely exclude a clot in the right patients, but they behave differently: the age-adjusted approach is slightly safer and rules out fewer people, while the probability-adapted one rules out more and leaves less margin. What this means for you: if your D-dimer is modestly raised and you are over 50, that alone may not warrant a scan, and asking which cutoff was used is a reasonable question.
Which D-dimer assay your laboratory uses actually matters
A 2025 secondary analysis of a large diagnostic study re-tested stored samples with five different D-dimer kits and found they do not classify patients identically; with two kits, a handful of people with a confirmed clot would have been labeled negative under an age-adjusted threshold. What this means for you: D-dimer numbers from different hospitals are not interchangeable, and a result should be interpreted by the team that ordered it.
Stopping treatment to test the water appears low risk
A 2025 systematic review pooling more than 11,000 people found that clots coming back in the first month after stopping anticoagulation are uncommon, on the order of one in a hundred, none fatal in the pooled data, and about two and a half times more likely after an unprovoked clot. What this means for you: if your team suggests a short pause in treatment to gauge your own recurrence risk, that strategy has reasonable evidence behind it.
Longer is not automatically better
A 2025 systematic review of 22 randomized trials found that in the initial treatment phase, extending anticoagulation beyond six months added little protection while roughly doubling the risk of serious bleeding; for long-term prevention after an unprovoked clot, however, continuing indefinitely reduced both recurrences and deaths, again at the cost of more bleeding. What this means for you: treatment length is a genuine trade-off rather than a fixed rule, and it deserves an explicit conversation.
Glossary
| Term | Definition |
|---|---|
| Anticoagulant | A medicine, often called a blood thinner, that slows clot formation. It does not dissolve a clot that already exists; it stops it from growing while the body clears it. |
| CTPA | Computed tomography pulmonary angiography. A CT scan with contrast dye that outlines the lung arteries so a clot shows up as a gap. It is the usual confirming test. |
| D-dimer | A fragment left over when the body breaks down a clot. Used to help rule a clot out, not to prove one. |
| Deep vein thrombosis | A clot in a deep vein, usually in the calf, thigh or pelvis. It is the most common source of a lung clot. |
| Sensitivity and specificity | Sensitivity is how well a test catches people who truly have the condition. Specificity is how well it avoids flagging people who do not. D-dimer scores high on the first and low on the second. |
| Provoked and unprovoked | A provoked clot has an identifiable trigger such as surgery or a long flight. An unprovoked clot has none, and carries a higher chance of coming back. |
| Thrombophilia | An inherited or acquired tendency to form clots more easily than usual. |
| Venous thromboembolism | The umbrella term covering both deep vein thrombosis and pulmonary embolism, since they are stages of one process. |
| Wells score | A structured checklist that turns clinical findings into a low, moderate or high probability of a lung clot, used before deciding on a D-dimer or a scan. |
Frequently asked questions
Can you have a pulmonary embolism without knowing it?
Yes, and it happens more often than most people expect. Small clots in the outer branches of the lung arteries can cause nothing more than mild breathlessness on exertion, a nagging cough, or a vague ache in the side of the chest. Some are found by accident on a scan ordered for another reason. That is precisely why the symptom pattern matters more than the intensity of any single symptom: new, unexplained breathlessness that does not fit your usual baseline is worth reporting, even if you feel able to carry on with your day.
What is the first sign of a pulmonary embolism?
For most people it is sudden shortness of breath, often with no obvious trigger and sometimes at rest. Chest pain that sharpens on breathing in is the next most common, and a fast heartbeat frequently accompanies both. There is no single reliable first sign, however, and a minority begin with fainting, light-headedness or an unexplained drop in exercise tolerance. Anyone with sudden breathlessness plus chest pain, coughing blood or fainting should treat it as an emergency and call 911 rather than trying to match their symptoms to a list.
Does a high D-dimer mean I have a blood clot?
No. A raised D-dimer means clot formation and breakdown are active somewhere in your body, which happens in pregnancy, infection, after surgery, with cancer, with liver or kidney disease, and simply with older age. The test earns its place because a normal result in someone judged low or moderate risk makes a lung clot very unlikely, allowing a scan to be avoided. A high result does not confirm anything on its own; it means imaging is needed to answer the question properly. Interpreting the number without the clinical context it was ordered in is the most common mistake patients make with this test.
Should I be tested for a clotting disorder after a pulmonary embolism?
Usually not routinely, and almost never during the acute episode or while you are on an anticoagulant, because both distort the results. Clotting-disorder testing is most useful when the answer would change something, for example a clot with no identifiable trigger in a younger person, a clot in an unusual location, recurrent pregnancy loss, or a strong family history. If it is done, it is generally scheduled after treatment has ended, and the results are best interpreted with a hematologist rather than read off a report.
How long will I need to take blood thinners?
At least three months for nearly everyone. After that, the decision depends on why the clot happened. If a temporary trigger such as surgery or a long flight explains it and that trigger is gone, treatment often stops at three months. If an ongoing condition such as active cancer explains it, treatment usually continues while that condition lasts. If no trigger was found, extended or indefinite treatment is often recommended, weighed against your individual bleeding risk. This is a shared decision, and it is reasonable to ask what your specific recurrence and bleeding estimates are.
Can flying cause a pulmonary embolism?
Long flights raise the risk modestly, mainly through several hours of immobility in a cramped position rather than anything about cabin pressure. The effect grows with flight duration, roughly from four hours upward, and matters far more when other factors are present, such as recent surgery, pregnancy, estrogen-containing contraception, obesity or a previous clot. Practical steps help: walk the aisle periodically, flex your ankles and calves while seated, drink water, and avoid sitting cross-legged for long stretches. If you have several risk factors, ask your clinician about compression stockings or preventive measures before you travel.
Sources
- Centers for Disease Control and Prevention — About Venous Thromboembolism (Blood Clots), 2024 — cdc.gov
- MedlinePlus, National Library of Medicine — Pulmonary Embolism, 2026 — medlineplus.gov
- Mayo Clinic — Pulmonary embolism: symptoms and causes, 2024 — mayoclinic.org
- van Es N, Takada T, Kraaijpoel N, et al. — Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis — European Heart Journal, 2023 — doi.org/10.1093/eurheartj/ehad417
- Righini M, Robert-Ebadi H, Le Gal G — Age-adjusted and clinical probability adapted D-dimer cutoffs to rule out pulmonary embolism: a narrative review of clinical trials — Journal of Clinical Medicine, 2024 — doi.org/10.3390/jcm13123441
- Robert-Ebadi H, Combescure C, Bulla O, et al. — Different D-dimer assays with age-adjusted cutoffs to exclude pulmonary embolism: secondary analysis of the ADJUST-PE study — Journal of Thrombosis and Haemostasis, 2025 — doi.org/10.1016/j.jtha.2025.04.007
- Eischer L, Kyrle PA, Kaider A, et al. — The incidence of early recurrent venous thromboembolism: a systematic review and meta-analysis — Research and Practice in Thrombosis and Haemostasis, 2025 — doi.org/10.1016/j.rpth.2025.103317
- Li A, Khatib R, Lopes LC, et al. — Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis — Blood Advances, 2025 — doi.org/10.1182/bloodadvances.2024015371
Further reading
- Readers monitoring their clotting often review a platelet count result
- Clot formation also involves a fibrinogen level
- Oxygen and acid-base reports include a base excess value
- Breathlessness sometimes signals congestive heart failure
- Anemia can worsen breathlessness, so many people also check a hemoglobin measurement
Understand your lab results with BloodSense
A pulmonary embolism workup produces a stack of numbers in a single afternoon: a D-dimer, a troponin, a natriuretic peptide, a blood count, kidney values and clotting times. Weeks later, those numbers are still on your patient portal without much explanation attached. BloodSense reads your lab report and explains, in plain language, what each value measures and what a result outside the reference range generally indicates. It helps you understand your results and prepare better questions; it does not diagnose, and it does not replace your doctor.
